Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $7.36 Million - $8.3 Million
-38,406 Reduced 43.07%
50,763 $10.8 Million
Q2 2023

Aug 11, 2023

SELL
$187.64 - $206.25 $2.76 Million - $3.03 Million
-14,701 Reduced 14.15%
89,169 $17.2 Million
Q1 2023

May 12, 2023

SELL
$127.59 - $203.08 $10.7 Million - $17 Million
-83,577 Reduced 44.59%
103,870 $21 Million
Q4 2022

Feb 13, 2023

BUY
$117.37 - $139.17 $136,383 - $161,715
1,162 Added 0.62%
187,447 $24.1 Million
Q3 2022

Nov 15, 2022

BUY
$135.27 - $180.11 $73,857 - $98,340
546 Added 0.29%
186,285 $25.5 Million
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $982,119 - $1.62 Million
9,026 Added 5.11%
185,739 $32.9 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $156,689 - $206,783
1,310 Added 0.75%
176,713 $25.5 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $2.51 Million - $3.37 Million
17,634 Added 11.18%
175,403 $27.1 Million
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $22.5 Million - $26.8 Million
157,769 New
157,769 $26.8 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.